Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1956309-69-5 | MDL No. : | MFCD27923707 |
Formula : | C11H7BrN4O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GCTJOJARNWILKM-UHFFFAOYSA-N |
M.W : | 291.10 | Pubchem ID : | 72710331 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 15 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 67.19 |
TPSA : | 63.57 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.93 cm/s |
Log Po/w (iLOGP) : | 1.97 |
Log Po/w (XLOGP3) : | 1.61 |
Log Po/w (WLOGP) : | 1.87 |
Log Po/w (MLOGP) : | 1.79 |
Log Po/w (SILICOS-IT) : | 2.23 |
Consensus Log Po/w : | 1.89 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.25 |
Solubility : | 0.165 mg/ml ; 0.000567 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.56 |
Solubility : | 0.808 mg/ml ; 0.00277 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.61 |
Solubility : | 0.00715 mg/ml ; 0.0000245 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.2 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
[ 148038-83-9 ]
6-Bromo-1H-imidazo[4,5-b]pyridin-2(3H)-one
Similarity: 0.66
[ 887433-64-9 ]
N1-(5-Bromopyrimidin-2-yl)-N2,N2-dimethylethane-1,2-diamine
Similarity: 0.65
[ 850349-22-3 ]
2-(Azetidin-1-yl)-5-bromopyrimidine
Similarity: 0.64
[ 77476-95-0 ]
(5-Bromopyrimidin-2-yl)isopropylamine
Similarity: 0.61
[ 887425-47-0 ]
1-(5-Bromopyrimidin-2-yl)piperidin-4-ol
Similarity: 0.60
[ 148038-83-9 ]
6-Bromo-1H-imidazo[4,5-b]pyridin-2(3H)-one
Similarity: 0.66
[ 2875-79-8 ]
N,N-Diphenyl-1H-imidazole-1-carboxamide
Similarity: 0.60
[ 374930-88-8 ]
tert-Butyl 4-(5-bromopyrimidin-2-yl)piperazine-1-carboxylate
Similarity: 0.60
[ 185961-99-3 ]
1-(Piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one
Similarity: 0.60
[ 21991-39-9 ]
3-Methyl-1H-imidazo[4,5-b]pyridin-2(3H)-one
Similarity: 0.59
[ 887433-64-9 ]
N1-(5-Bromopyrimidin-2-yl)-N2,N2-dimethylethane-1,2-diamine
Similarity: 0.65
[ 850349-22-3 ]
2-(Azetidin-1-yl)-5-bromopyrimidine
Similarity: 0.64
[ 77476-95-0 ]
(5-Bromopyrimidin-2-yl)isopropylamine
Similarity: 0.61
[ 887425-47-0 ]
1-(5-Bromopyrimidin-2-yl)piperidin-4-ol
Similarity: 0.60
[ 374930-88-8 ]
tert-Butyl 4-(5-bromopyrimidin-2-yl)piperazine-1-carboxylate
Similarity: 0.60
[ 90871-47-9 ]
2-Amino-1-isopropylbenzimidazole
Similarity: 0.56
[ 305790-48-1 ]
6-Bromo-1-methyl-1H-benzo[d]imidazol-2(3H)-one
Similarity: 0.56
[ 2851-13-0 ]
N,N-Dimethyl-1H-benzo[d]imidazol-2-amine
Similarity: 0.55
[ 57667-50-2 ]
1-Propyl-1H-benzo[d]imidazol-2-amine
Similarity: 0.54
[ 10045-45-1 ]
1-Ethyl-1H-benzo[d]imidazol-2(3H)-one
Similarity: 0.54